Calliditas Therapeutics AB Impairment Loss
Calliditas Therapeutics AB reported Impairment Loss of SEK 0 for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLoss · last filed 2023-04-26
| Period end | Impairment Loss 12 month |
|---|---|
| 2022-12-31 | 0.00 SEK 20-F · filed 2023-04-26 |
| 2021-12-31 | 0.00 SEK 20-F · filed 2022-04-27 |
| 2020-12-31 | 0.00 SEK 20-F/A · filed 2022-01-14 |